Investing Profile

Eric Shiozaki

VCInvestor
Venture Partner at Revelation Partners
dcvc.com/bio/core/dr-eric-shi...San Francisco, California
Photo of Eric Shiozaki, Venture Partner at Revelation Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Princeton University Network
356 CONNECTIONS
The Johns Hopkins University Network
155 CONNECTIONS
UCLA Fielding School of Public Health Network
39 CONNECTIONS
UCLA Fielding School of Public Health Network
39 CONNECTIONS
Princeton University Investment Company Network
37 CONNECTIONS
cb
Revelation Partners Venture Partner
$5.0M - $25.0M
$15.0M
4
CompanyStageDateRound SizeTotal Raised
VitalConnect
Series UnknownFeb 2025$100M
$100M
Radionetics Oncology
Series AAug 2023$53M
$83M
Co-investors: David Allison (Westlake Village BioPartners), Daniel Estes (Frazier Life Sciences)
Ascend Gene & Cell Therapies
Series AMar 2023$66M
$66M
Co-investors: Andrew Kozlov (4BIO Capital), Bali Muralidhar (Abingworth), Andrew Sinclair (Abingworth)
Auron Therapeutics
Series AJul 2022$48M
$88M
Co-investors: Alexandra Cantley (Polaris Partners), Marianne Mertens (Apollo Health Ventures), Isaac Ciechanover (Qiming Venture Partners USA), Daniel Coley (Cofounders Capital)
Postdoctoral Researcher Princeton University Investment CompanyPresent
Leukemia & Lymphoma Society Postdoctoral Fellow UCLA Fielding School of Public HealthPresent
Technology Transfer Associate UCLA Fielding School of Public HealthPresent
Intern Burrill & CompanyPresent
Associate Burrill & CompanyPresent
Director of Corporate Development & Strategy VitaPath GeneticsPresent
Associate Director Apposite CapitalPresent
Director Apposite CapitalPresent
Principal - Novo Ventures Novo HoldingsPresent
Partner - Novo Ventures Novo HoldingsPresent
Venture Partner Revelation PartnersPresent
The Johns Hopkins University BA Biophysics
Princeton University Ph.D. Molecular Biology
Sign in with Google →
Sign in with Google →